[ORGANIZATION]
Shanghai Henlius Biotech
Featured in 2 tracked stories · first seen
Situations
Expansion of semaglutide generic and biosimilar markets
2 clusters · 12 sources · last updated
Latest: Sandoz targets biosimilar growth and generic semaglutide expansion
The pharmaceutical market for semaglutide-based medications is expanding through the introduction of generic and biosimilar alternatives. In Brazil, the National Health Surveillance Agency (Anvisa) approved new injectabl
Also covered in
-
Sandoz and Henlius Biotech sign $322 million biosimilar deal
[BUSINESS] · 12 sources ·